These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21623910

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.
    Bröcker V, Schubert V, Scheffner I, Schwarz A, Hiss M, Becker JU, Scherer R, Haller H, Kreipe HH, Mengel M, Gwinner W.
    Am J Pathol; 2012 May; 180(5):1852-62. PubMed ID: 22464889
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
    Okamoto M, Akioka K, Ushigome H, Higuchi A, Nobori S, Ogino S, Uryuhara K, Kaihara S, Hatta T, Urasaki K, Yoshimura N.
    Clin Transplant; 2006 May; 20 Suppl 15():16-9. PubMed ID: 16848870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.
    Snanoudj R, Royal V, Elie C, Rabant M, Girardin C, Morelon E, Kreis H, Fournet JC, Noël LH, Legendre C.
    Am J Transplant; 2011 Dec; 11(12):2635-46. PubMed ID: 21883915
    [Abstract] [Full Text] [Related]

  • 8. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
    Kubal C, Cockwell P, Gunson B, Jesky M, Hanvesakul R, Dronavalli V, Bonser RS, Neil D.
    Transplantation; 2012 Feb 27; 93(4):406-11. PubMed ID: 22217532
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
    Kushwaha SS, Khalpey Z, Frantz RP, Rodeheffer RJ, Clavell AL, Daly RC, McGregor CG, Edwards BS.
    J Heart Lung Transplant; 2005 Dec 27; 24(12):2129-36. PubMed ID: 16364861
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ, Gimson AE, Alexander GJ, Allison ME, Gibbs P, Smith JC, Palmer CR, Bradley JA.
    Liver Transpl; 2007 Dec 27; 13(12):1694-702. PubMed ID: 18044728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
    Issa N, Kukla A, Ibrahim HN.
    Am J Nephrol; 2013 Dec 27; 37(6):602-12. PubMed ID: 23796509
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I, Chan L.
    Transplant Proc; 2011 Mar 27; 43(2):472-7. PubMed ID: 21440737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.